Carlsmed, Inc.
NASDAQ · us_market
No AI insight generated yet for this ticker.
Carlsmed, Inc., a commercial-stage medical technology company, designs, manufactures, and markets AI-enabled personalized spine surgery solutions. The company develops aprevo, a comprehensive technology platform for spine fusion surgery procedures. Its aprevo platform includes proprietary surgical planning software, using outcomes-based algorithms that are aided with artificial intelligence, and resulting custom-built, anatomically designed vertebral interbody implants. The company was incorporated in 2018 and is based in Carlsbad, California.
| Fund | Style | Shares | Value | % of Port | Change vs. last quarter | Period |
|---|---|---|---|---|---|---|
| StateStreet | passive | 113.7K | $1.03M | 0.00% | Added+64.9% | 2026-03-31 |
| RenTech | quant | 10.4K | $94.12K | 0.00% | Trimmed-57.2% | 2026-03-31 |
| FidelityFMR | fundamental | 1.3K | $11.73K | 0.00% | Added+322.1% | 2026-03-31 |
| Report Date | EPS Estimate | EPS Actual | Surprise |
|---|---|---|---|
| 2026-08-05upcoming | -0.39 | — | — |
| 2026-05-05 | -0.39 | -0.26 | +33.34% |
| 2026-02-25 | -0.43 | -0.29 | +31.54% |
| 2025-11-06 | -0.49 | -0.37 | +24.51% |
| 2025-08-28 | -0.91 | -1.37 | -49.32% |
| 30d | 90d | YTD | 1y | |
|---|---|---|---|---|
| CARL | +20.46% | -13.55% | -7.53% | — |
| XLV | +2.97% | -4.64% | -3.44% | +12.69% |
| Alpha (stock − sector) | +17.49% | -8.91% | -4.09% | — |